Sequent Scientific Update by Epic Research

Sequent Scientific has received its board approval to raise funds up to Rs 400 crore through the issue of GDRs/ ADRs/ FCCBs/ QIP/ such other equity-linked instruments, etc, subject to approval of members and other regulatory approvals. Further, the company has received approval to increase in the limit of investments by Foreign Institutional Investors (FIIs) in the equity share capital of the Company upto 49% of the paid up capital of the Company, subject to approval of the Members and any other statutory / regulatory approvals as may be required.



Real Time News & Trading Trends Keep Liking Epic Research Private Limited



Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips